CompanyOverview\|NASDAQ:MRNA] The CEO of Moderna Inc. (NASDAQ: MRNA) just purchased $5 million of stock in the open market.

Moderna's President Stephen Hoge stated, “As you know, and as I mentioned, there are additional Phase 3s as well as two randomized Phase 2s, including bladder cancer and renal cell carcinoma ...

The primary endpoint is recurrence-free survival at 12 months, with first results expected late this quarter, according to Moderna's president, Stephen Hoge. "We continue to be excited about the ...

Meanwhile, president Stephen Hoge, MD received $9.1 million last year — up from $7.3 million in 2023. Cardinal Health CEO Jason Hollar received $25.7 million in total direct compensation in 2024 — up ...

As we approach the 2025 NCAA Championships in Philadelphia, the Panthers have put themselves in a good spot to do just that. A 14-1 dual record (best since 1991), 10 NCAA qualifiers (first time since ...